Add-on fenfluramine in Lennox Gastaut epilepsy

Trial Profile

Add-on fenfluramine in Lennox Gastaut epilepsy

Phase of Trial: Phase II

Latest Information Update: 05 Dec 2017

At a glance

  • Drugs Fenfluramine (Primary)
  • Indications Lennox-Gastaut syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Dec 2017 Interim results (n=13) assessing the efficacy and tolerability of low-dose Fenfluramine (ZX008) in patients with Lennox-Gastaut Syndrome, presented at the 71st Annual Meeting of the American Epilepsy Society.
    • 21 Nov 2017 According to a Zogenix media release, data will be presented at the 71st American Epilepsy Society (AES) Annual Meeting and will also be presented in a Zogenix-hosted Scientific Exhibit Room Dec 2017.
    • 05 Dec 2016 According to a Zogenix media release, interim analysis data from this study were presented at the 70th Annual American Epilepsy Society (AES) meeting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top